Clinical trials of a new polytetrafluoroethylene-silicone graft

Am J Surg. 1989 Aug;158(2):117-20. doi: 10.1016/0002-9610(89)90358-9.

Abstract

A self-sealing polytetrafluoroethelene (PTFE)-silicone graft designed to be used early after implantation was placed in 30 end-stage renal disease patients. Thirty-five conventional PTFE grafts were used in the control group. All patients were followed for 1 year. In the PTFE-silicone graft group, median time for first use was 1 day after implantation. Conventional PTFE grafts were first used 2 to 4 weeks after implantation. Early punctures of the PTFE-silicone grafts (first 10 sessions), although more difficult to perform than late punctures, were not more difficult than punctures of conventional PTFE grafts. Late punctures in PTFE-silicone grafts were easier than conventional PTFE graft punctures. Bleeding after needle removal was significantly decreased after early and late punctures of PTFE-silicone grafts compared with conventional PTFE grafts (p less than 0.001). The PTFE-silicone graft can be used immediately after implantation, sparing patients additional access procedures for short-term dialysis. This results in less morbidity, decreased bleeding complications, shorter hospital stay, and a significant reduction in expenses.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Vessel Prosthesis*
  • Clinical Trials as Topic
  • Humans
  • Kidney Failure, Chronic / surgery*
  • Middle Aged
  • Polytetrafluoroethylene*
  • Prosthesis Failure
  • Renal Dialysis
  • Silicone Elastomers*

Substances

  • Silicone Elastomers
  • Polytetrafluoroethylene